Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells-Reference-Cited by-同舟云学术

Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells

Published:2016-01 Issue: Volume:29 Page:103-111
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Ueda Kosuke,Akiba Jun,Ogasawara Sachiko,Todoroki Keita,Nakayama Masamichi,Sumi Akiko,Kusano Hironori,Sanada Sakiko,Suekane Shigetaka,Xu Keming,Bae Ki Hyun,Kurisawa Motoichi,Igawa Tsukasa,Yano Hirohisa

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference32 articles.

1. Cytokine therapy in renal cell cancer;Vuky;Urol. Oncol.,2000

2. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d’Immunotherapie;Negrier;N. Engl. J. Med.,1998

3. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res.,2004

4. Mechanism of synergistic antitumor effect of sorafenib and interferon-alpha on treatment of renal cell carcinoma;Takeuchi;J. Urol.,2010

5. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines;Tochizawa;Biomed. Res.,2008

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials;Materials Today Bio;2024-08

2. Engineered Bio‐Based Hydrogels for Cancer Immunotherapy;Advanced Materials;2024-02-22

3. Exosomes encapsulated in hydrogels for effective central nervous system drug delivery;Biomaterials Science;2024

4. Injectable hydrogels for personalized cancer immunotherapies;Acta Biomaterialia;2023-12

5. Biomaterial-based delivery platforms for transdermal immunotherapy;Biomedicine & Pharmacotherapy;2023-09